Type
Blood Testing
Biomarkers
9
Duration
15 min
An integrated cardiovascular risk panel combining the full lipid profile with fasting glucose and kidney function markers. Provides a broader cardiovascular assessment than the standalone cholesterol panel by adding metabolic and renal parameters that independently influence heart disease risk.
Cardiovascular risk is multifactorial, and a lipid profile alone — while essential — captures only one dimension. This panel expands the assessment by adding fasting glucose and kidney function markers, both of which are independent risk factors for cardiovascular events and are included in major European risk scoring models. Fasting glucose identifies early blood sugar dysregulation, including prediabetes, which approximately doubles the risk of cardiovascular disease even before a formal diabetes diagnosis. Kidney function — assessed through creatinine and estimated glomerular filtration rate (eGFR) — is relevant because reduced renal clearance accelerates atherosclerosis and is associated with elevated blood pressure and altered lipid metabolism. The combination of lipid, glucose, and renal markers provides a more complete risk picture than any single domain alone. This panel is positioned between the standalone cholesterol test and the general health screening in both scope and price. It is well suited for individuals with a family history of heart disease, those with borderline cholesterol results who want additional metabolic context, or anyone seeking a focused cardiovascular risk assessment without the breadth of a full general screening. Fasting is recommended for accurate glucose and triglyceride measurement — no food for 10 to 12 hours before the draw, with water permitted.
Key Details
- Biomarkers
- 7
- Fasting
- Recommended
- Results
- Next business day
- Lab
- ISO 15189 certified
Who Is This For?
Cardiovascular risk profiling, family history of heart disease, metabolic health assessment, individuals with borderline cholesterol seeking broader context
What's Included
Preparation Required
Fasting recommended: no food for 10-12 hours before the blood draw. Water is permitted.
Panel Categories
Biomarkers Tested
9The primary protein on LDL and VLDL particles. Each atherogenic lipoprotein particle carries exactly one ApoB molecule, making it a direct measure of the number of particles that can enter artery walls. Considered a superior predictor of cardiovascular risk compared to LDL cholesterol.
A protein produced by the liver in response to inflammation. CRP rises rapidly during infection, injury, or inflammatory conditions. It's a general marker — elevated CRP signals inflammation but doesn't pinpoint the source.
A protein essential for blood clotting that also serves as an inflammation marker. Elevated fibrinogen increases blood viscosity and clot risk, contributing to cardiovascular disease independent of cholesterol levels.
An amino acid produced during protein metabolism. Elevated homocysteine is an independent risk factor for cardiovascular disease, stroke, and cognitive decline. Levels are lowered by adequate B12, folate, and B6 intake.
A highly sensitive test for low-grade chronic inflammation linked to cardiovascular disease risk. Lower hs-CRP values are associated with better cardiovascular outcomes.
Often called 'bad' cholesterol, LDL deposits cholesterol in artery walls, contributing to plaque buildup and atherosclerosis. LDL is the primary target for cardiovascular risk reduction through diet, exercise, and medication.
Lp(a) is a cholesterol-carrying particle linked to genetic risk for heart disease. High levels increase cardiovascular risk.
Marker of heart stress and function
Troponin is a protein involved in heart muscle contraction. Elevated levels are a marker of heart damage, often used to diagnose heart attacks.